NI Technology Research Previews Earnings for Bookham, Avanex, Emulex, Actel, Anadigics, Cerner, and Semitool
April 27 2009 - 12:06PM
PR Newswire (US)
PRINCETON, N.J., April 27 /PRNewswire/ -- Next Inning Technology
Research (http://www.nextinning.com/), an online investment
newsletter focused on semiconductor and technology stocks,
announced it has previewed earnings for Bookham (NASDAQ:BKHM),
Avanex (NASDAQ:AVNX), Emulex (NYSE:ELX), Actel (NASDAQ:ACTL),
Anadigics (NASDAQ:ANAD), Cerner (NASDAQ:CERN), Semitool
(NASDAQ:SMTL) and many others. Throughout this challenging period
in the market, Editor Paul McWilliams has helped his subscribers
identify uniquely positioned tech sector opportunities. Some of
these stocks appreciated nearly 200% in only months. Due to this
rapid appreciation, McWilliams has more recently suggested thinning
certain speculative holdings and provided specific examples showing
readers how to use options to reduce risks. The results speak for
themselves; on a year-to-date basis, the Next Inning model
portfolio has returned 41%, significantly ahead of the 8% return by
the Nasdaq over that period. By taking a free test drive of Next
Inning, you'll receive free copies of the newly updated "Guide to
Undervalued Tech Stocks" and supporting State of Tech reports as
they are released. These reports cover 79 technology companies and
are chock full of actionable commentary and ratings that identify
potential big winners and which stocks investors should avoid. To
gain immediate access to the service, visit the following link:
https://www.nextinning.com/subscribe/index.php?refer=prn815
McWilliams covers these topics: -- McWilliams wrote a special
report covering five of the primary players in the optical sector
last November. In the report, he listed Bookham as his favorite
speculative play. It has since gone up 75%. How does McWilliams
view the company now that it is scheduled to merge with Avanex?
Which does he think presents the better value? -- McWilliams
advised readers last week that Broadcom would have to sweeten its
offer to get a deal closed with Emulex. Does he still think that
will be the case? Why does he think Broadcom is so interested in
broadening its interests in data center applications? In addition
to his Emulex earnings preview, Emulex shareholders will find
interest in his updated strategy review that was also published
this morning. -- The price of Anadigics has moved up over 135%
since McWilliams listed the stock as a good speculative investment
last December. He reiterated the call to buy in March and it's up
50% from that level. What is it McWilliams sees working in
Anadigics' favor that Wall Street was obviously slow to recognize?
Does he think investors should still consider buying the stock at
its current price? -- McWilliams says Cerner is poised to benefit
from health care reform legislation, but there are two issues
investors should consider before buying. -- McWilliams alerted
readers in early March there was news coming from his Asian
contacts that suggested better times were ahead for Semitool. Since
publishing that report, the stock has moved up 80%. What was the
news and does he think there is still more room for appreciation?
Founded in September 2002, Next Inning's model portfolio has
returned 187% since its inception versus 31% for the Nasdaq. About
Next Inning: Next Inning is a subscription-based investment
newsletter that provides regular coverage on more than 150
technology and semiconductor stocks. Subscribers receive intra-day
analysis, commentary and recommendations, as well as access to
monthly semiconductor sales analysis, regular Special Reports, and
the Next Inning model portfolio. Editor Paul McWilliams is a
25+-year semiconductor industry veteran. NOTE: This release was
published by Indie Research Advisors, LLC, a registered investment
advisor with CRD #131926. Interested parties may visit
adviserinfo.sec.gov for additional information. Past performance
does not guarantee future results. Investors should always research
companies and securities before making any investments. Nothing
herein should be construed as an offer or solicitation to buy or
sell any security. CONTACT: Marcia Martin, Next Inning Technology
Research, +1-888-278-5515 DATASOURCE: Indie Research Advisors, LLC
CONTACT: Marcia Martin, Next Inning Technology Research,
+1-888-278-5515 Web Site: http://www.nextinning.com/
Copyright
Bookham (MM) (NASDAQ:BKHM)
Historical Stock Chart
From Jul 2024 to Aug 2024
Bookham (MM) (NASDAQ:BKHM)
Historical Stock Chart
From Aug 2023 to Aug 2024